PRESS RELEASE published on 08/25/2025 at 08:00, 7 months 2 days ago Informations privilégiées / Autres communiqués TME Pharma lève 500 000 € via une émission obligataire pour accélérer ses activités de développement de thérapies innovantes. Nouveau soutien financier renforce la position de TME Pharma Développement Financement Émission Obligataire TME Pharma Thérapies Innovantes
BRIEF published on 07/08/2025 at 08:05, 8 months 19 days ago TME Pharma met fin à son contrat de liquidité dans le cadre d'une optimisation des coûts Contrat De Liquidité Biotechnologie Optimisation Des Coûts Refinancement TME Pharma
BRIEF published on 07/08/2025 at 08:05, 8 months 19 days ago TME Pharma Terminates Liquidity Contract Amid Cost Optimization Liquidity Contract Biotechnology Refinancing Cost Optimization TME Pharma
PRESS RELEASE published on 07/08/2025 at 08:00, 8 months 19 days ago Informations privilégiées / Autres communiqués TME Pharma annonce la résiliation du contrat de liquidité avec Invest Securities pour optimiser ses coûts et renforcer sa trésorerie. Réduction des coûts opérationnels suite à la restructuration organisationnelle Contrat De Liquidité Optimisation Des Coûts TME Pharma Restructuration Organisationnelle Développement Thérapies
PRESS RELEASE published on 07/08/2025 at 08:00, 8 months 19 days ago Inside Information / Other news releases TME Pharma terminates liquidity contract with Invest Securities to optimize costs. Improve trading volume of shares and healthy liquidity deemed contract unnecessary. Finds success in refinancing and reducing operational costs Liquidity Contract Cost Optimization Trading Volume Organizational Restructuring TME Pharma
BRIEF published on 05/21/2025 at 08:05, 10 months 6 days ago TME Pharma Enhances Financial Outlook with €1.7M Bond Commitments Strategic Partnerships Bond Issuance Clinical Programs Financial Visibility Cost Structure
BRIEF published on 05/21/2025 at 08:05, 10 months 6 days ago TME Pharma améliore ses perspectives financières avec un engagement obligataire de 1,7 million d'euros Partenariats Stratégiques Emission D'obligations Programmes Cliniques Visibilité Financière Structure Des Coûts
PRESS RELEASE published on 05/21/2025 at 08:00, 10 months 6 days ago Informations privilégiées / Autres communiqués TME Pharma, société de biotechnologie spécialisée en thérapies contre le cancer, prolonge sa visibilité financière jusqu'en mai 2026 via une émission d'obligations aux investisseurs professionnels Investisseurs Obligations Cancer Visibilité Financière TME Pharma
PRESS RELEASE published on 05/21/2025 at 08:00, 10 months 6 days ago Inside Information / Other news releases TME Pharma extends financial visibility to May 2026 by securing €1.7M financing through regular bonds with attached warrants. CEO and board show strong commitment to company's success Clinical Programs TME Pharma Financial Visibility Regular Bonds Private Warrants
BRIEF published on 04/10/2025 at 19:05, 11 months 16 days ago TME Pharma strengthens its liquidity contract with Invest Securities Liquidity Contract Oncology INVEST SECURITIES Financial Markets TME Pharma
Published on 03/27/2026 at 08:05, 59 minutes ago Battery X Metals Announces Corporate Awareness Engagements
Published on 03/26/2026 at 23:00, 10 hours 4 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 10 hours 59 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 11 hours 4 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 11 hours 4 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/27/2026 at 08:00, 1 hour 4 minutes ago ENERGISME: Des fonds investissent 5 M€ dans Energisme pour le développement de Loamics, sa filiale santé
Published on 03/27/2026 at 07:45, 1 hour 19 minutes ago Pyrum Innovations AG publishes preliminary results for financial year 2025
Published on 03/27/2026 at 07:30, 1 hour 33 minutes ago DKSH Performance Materials Acquires AIC Ingredients, a Leading Customized Food Solutions Manufacturer in Malaysia
Published on 03/27/2026 at 07:30, 1 hour 33 minutes ago Haier Celebrates Excellence in Paris With New Smart Home Portfolio
Published on 03/27/2026 at 07:00, 2 hours 4 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 14 hours 47 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 14 hours 47 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 15 hours 4 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
